Zobrazeno 1 - 10
of 87
pro vyhledávání: '"R, Koelemij"'
Autor:
K. Bokkers, E.M.A. Bleiker, M.E. Velthuizen, R. Koelemij, J.P.J. Burgmans, J.H. Klinkenbijl, A.P. Schouten van der Velden, N. Vermulst, B.F. Huizinga, A.J. Witkamp, T. Frakking, R.M. Brohet, C.M. Aalfs, W. Koole, E.J.P. Schoenmaeckers, M.G.E.M. Ausems
Publikováno v:
Breast, Vol 69, Iss , Pp 349-357 (2023)
Background: Pre-test genetic counseling of patients with breast cancer is increasingly being offered by non-genetic healthcare professionals. We aimed to evaluate the experiences of patients with breast cancer receiving pre-test genetic counseling fr
Externí odkaz:
https://doaj.org/article/5c9933891d8d4c659e2f39ea626f4f76
Autor:
I. A. A. Perfors, C. W. Helsper, E. A. Noteboom, E. A. Visserman, E. B. L. van Dorst, T. van Dalen, M. A. M. T. Verhagen, A. J. Witkamp, R. Koelemij, A. E. Flinterman, K. A. B. M. Pruissen-Peeters, F. M. N. H. Schramel, M. T. M. van Rens, M. F. Ernst, L. M. G. Moons, E. van der Wall, N. J. de Wit, A. M. May
Publikováno v:
BMC Primary Care, Vol 23, Iss 1, Pp 1-14 (2022)
Abstract Background The growing number of cancer survivors and treatment possibilities call for more personalised and integrated cancer care. Primary care seems well positioned to support this. We aimed to assess the effects of structured follow-up o
Externí odkaz:
https://doaj.org/article/62b831d00a5140ffb4d8dea797e9fc59
Autor:
Philip J van der Wees, Paul B van der Nat, Noel Engels, Steven Teerenstra, Sabine Siesling, R Saxena, Cornelia F van Uden-Kraan, Willem Jan W Bos, Sander M van Schaik, Renske M van den Berg-Vos, Mariska Quirina Nikita Hackert, Jet W Ankersmid, Janine C M Prick, Constance H C Drossaert, Luc J A Strobbe, Yvonne E A van Riet, René M A van den Dorpel, Mirjam M Garvelink, YEA van Riet, LJA Strobbe, AE Dassen, AFT Olieman, HHG Witjes, R Koelemij, A Doeksen, CME Contant, PJAM Brouwers, GW van Dijk, RAR Gons, PHE Hilkens, SM van Schaik, ES Schut, WJW Bos, MA van den Dorpel, CEH Siegert, CJAM Konings, CG ter Meulen, WMT Janssen, JN Brinkman
Publikováno v:
BMJ Open, Vol 12, Iss 8 (2022)
Introduction Within the value-based healthcare framework, outcome data can be used to inform patients about (treatment) options, and empower them to make shared decisions with their health care professional. To facilitate shared decision-making (SDM)
Externí odkaz:
https://doaj.org/article/66df18e782014693962eb10a8806abac
Autor:
R. Koelemij, Eleonora B.L. van Dorst, Ietje A A Perfors, Annebeth E Flinterman, Marc A M T Verhagen, Charles W Helsper, Ella A Visserman, Elsken van der Wall, Anne M. May, Thijs van Dalen, Leon M G Moons, Marcel T M van Rens, Franz M N H Schramel, Niek J. de Wit, Kim A B M Pruissen-Peeters, Eveline A Noteboom, Arjen J. Witkamp, Miranda F. Ernst
Publikováno v:
Psycho-Oncology
Objective Improving shared decision‐making (SDM) enables more tailored cancer treatment decisions. We evaluated a Time Out consultation (TOC) with the general practitioner (GP), between cancer diagnosis and treatment decision, which aims at support
Autor:
A.M. Gijs van Leeuwen, Wouter B. Veldhuis, Jeanine E. Vasmel, Arjen J Witkamp, Marielle E.P. Philippens, Helena M. Verkooijen, Elsken van der Wall, Joost van Gorp, Thijs van Dalen, Anna M. Kirby, Paul J. van Diest, H.J.G. Desiree van den Bongard, Antonetta C. Houweling, Iris E. van Dam, Celien P.H. Vreuls, R. Koelemij, M. Sier, Bram van Asselen, Ramona K. Charaghvandi, A. Doeksen
Publikováno v:
International Journal of Radiation Oncology, Biology, Physics, 106, 4, pp. 821-829
International Journal of Radiation Oncology Biology Physics, 106(4), 821. Elsevier Inc.
International Journal of Radiation Oncology, Biology, Physics, 106, 821-829
International Journal of Radiation Oncology Biology Physics, 106(4), 821-829. Elsevier Inc.
International Journal of Radiation Oncology Biology Physics, 106(4), 821. Elsevier Inc.
International Journal of Radiation Oncology, Biology, Physics, 106, 821-829
International Journal of Radiation Oncology Biology Physics, 106(4), 821-829. Elsevier Inc.
Contains fulltext : 219916.pdf (Publisher’s version ) (Closed access) PURPOSE: To assess the pathologic and radiologic response in patients with low-risk breast cancer treated with magnetic resonance (MR) guided neoadjuvant partial breast irradiati
Autor:
C. H. M. van Deurzen, R. van Hillegersberg, M. G. G. Hobbelink, C. A. Seldenrijk, R. Koelemij, P. J. van Diest
Publikováno v:
Cellular Oncology, Vol 29, Iss 6, Pp 497-505 (2007)
Background: The need for routine axillary lymph node dissection (ALND) in patients with invasive breast cancer and low-volume sentinel node (SN) involvement is questionable. Accurate prediction of second echelon lymph node involvement could identify
Externí odkaz:
https://doaj.org/article/d7f06f96c9064a9aa4e1a1e8ceeecea8
Autor:
G.A.P. Nieuwenhuijzen, R.A. Hellingman, Franchette W P J van den Berkmortel, S. Hovenga, H.M. Oosterkamp, T. van Dalen, Sabine C. Linn, E.J. van Dulken, Rudi M. H. Roumen, Maurice J.C. van der Sangen, R.C. van Doorn, M.O. den Boer, R. den Toom, Carolien H. Smorenburg, J.J.M. van der Hoeven, Aafke H. Honkoop, Irene E. G. van Hellemond, H. Potthoff, R. Koelemij, Frans L. G. Erdkamp, A. van Bochove, W.G. van Leeuwen-Breuk, R.J.B. Blaisse, A.M.T. van der Velden, Yvonne Kamm, E.J.C. Vriens, Judith R. Kroep, Erik W. Muller, W.J.B. Mastboom, R. van Hillegersberg, P.C. van der Velden, T. van Voorthuizen, Vivianne C. G. Tjan-Heijnen, J.M. Meerum Terwogt, M.M. Vleugel, A. Vos, J.J. Jansen, Jos J. E. M. Kitzen, G.S. Madretsma, R. Vree, J.K.S. Nuytinck, Luc J. A. Strobbe, J.H. van Dam, P.H.A. Nijhuis, Wilfred K. de Roos, P.P.J.B.M. Schiphorst, B. Jas, E.E.M. Schepers, Q. van Rossum-Schornagel, Petronella G. M. Peer, C.J. van Groeningen, J.G. Haasjes, M.J. Agterof, E.A. Kouwenhoven, Alexander L T Imholz, Caroline M. Seynaeve, M.A. Davidis-van Schoonhoven, M.A.J. de Roos, M.J.P.M. Govaert, J.M.A. Ketel, J.M.G.H. van Riel, M. Jagers, A.J. van Overbeeke, Aart Beeker, J.K. Maring, G.J. Veldhuis, J.W.S. Merkus, Maaike de Boer, Onno R. Guicherit, H.B.A.C. Stockmann, E. Janssens van Vliet, J. de Boer, D.F.S. Kehrer, I.E. Arntz, N.G.J. van Diemen, Koop Bosscha, Hiltje de Graaf, F.A.A. Valster, E.E.M. Weernink, C.T.A.M. van Rossum, M.A. van Dijk, B.C. Tanis, Astrid C P Swinkels, E.J.M. Siemerink, D.W. Sommeijer
Publikováno v:
Tjan-Heijnen, V C G, van Hellemond, I E G, Peer, P G M, Swinkels, A C P, Smorenburg, C H, van der Sangen, M J C, Kroep, J R, De Graaf, H, Honkoop, A H, Erdkamp, F L G, van den Berkmortel, F W P J, de Boer, M, de Roos, W K, Linn, S C, Imholz, A L T, Seynaeve, C M & Dutch Breast Cancer Research Group (BOOG) for the DATA Investigators 2017, ' Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA) : a randomised, phase 3 trial ', The Lancet Oncology, vol. 18, no. 11, pp. 1502-1511 . https://doi.org/10.1016/S1470-2045(17)30600-9
The Lancet Oncology, 18(11), 1502-1511
Lancet Oncology, 18, 11, pp. 1502-1511
LANCET ONCOLOGY, 18(11), 1502. Lancet Publishing Group
The Lancet Oncology, 18(11), 1502-1511. Lancet Publishing Group
Lancet oncology, 18(11), 1502-1511. Elsevier Science
Lancet Oncology, 18(11), 1502-1511. Lancet Publishing Group
Lancet Oncology, 18, 1502-1511
The Lancet Oncology, 18(11), 1502-1511
Lancet Oncology, 18, 11, pp. 1502-1511
LANCET ONCOLOGY, 18(11), 1502. Lancet Publishing Group
The Lancet Oncology, 18(11), 1502-1511. Lancet Publishing Group
Lancet oncology, 18(11), 1502-1511. Elsevier Science
Lancet Oncology, 18(11), 1502-1511. Lancet Publishing Group
Lancet Oncology, 18, 1502-1511
Item does not contain fulltext BACKGROUND: The effect of extended adjuvant aromatase inhibition in hormone receptor-positive breast cancer after sequential endocrine therapy of tamoxifen followed by an aromatase inhibitor for a 5-year treatment perio
Autor:
Carla H. van Gils, Desirée H.J.G. van den Bongard, Arjen J. Witkamp, R. Koelemij, Rhodé M Bijlsma, Yvette Jonasse, M.L. Gregorowitsch, Ine Burgmans, Carmen C. van der Pol, Helena M. Verkooijen, Danny A. Young-Afat, E J P Schoenmaeckers
Publikováno v:
JNCI Cancer Spectrum
JNCI cancer spectrum, 3(2)
JNCI cancer spectrum, 3(2)
Background The association between lymphedema of the arm and impaired health-related QoL (HR-QoL) has led to changes in clinical practice. However, data on lymphedema of the breast (ie, breast edema) are lacking. We prospectively evaluated patient-re
Autor:
Monique G.G. Hobbelink, C. C. van der Pol, G. Van Leeuwen, Arjen J. Witkamp, P. J. Van Diest, A. Doeksen, R. Koelemij, D. Van den Bongard, M. Sier, E. van der Wall, T. van Dalen, J. van Gorp, Helena M. Verkooijen, Jeanine E. Vasmel, Ramona K. Charaghvandi, M.E.P. Philippens, Wouter B. Veldhuis, C. Vreuls, Antonetta C. Houweling, Anna M. Kirby
Publikováno v:
Radiotherapy and Oncology. 133:S309-S310
Publikováno v:
Breast Cancer Research and Treatment
Breast cancer research and treatment, 164(2), 445-450. Springer New York
Breast Cancer Research and Treatment, 164(2), 445. Springer New York
Breast cancer research and treatment, 164(2), 445-450. Springer New York
Breast Cancer Research and Treatment, 164(2), 445. Springer New York
PURPOSE: In oncology, RCTs are often beset by slow recruitment, limited generalizability, and strong preferences for interventions by patients and physicians. The cohort multiple randomized controlled trial (cmRCT) is an innovative design with the po